X

Vous n'êtes pas connecté

  - PHARMABIZ.COM - A la Une - 12/Jul 13:41

Osivax publishes phase 2a results of OVX836─004 study; supports co─administration of OVX836 with seasonal flu vaccine

Osivax, a biopharmaceutical company developing vaccines to provide broad─spectrum protection against highly mutating infectious viruses, announced the publication of positive results from its phase 2a, OVX836─004, study in the journal vaccines.

Articles similaires

SolasCure publishes Dose Escalation Study on painless application of Aurase Wound Gel

news.medical.net - 08/Jul 11:08

SOLASCURE Ltd (SolasCure), a biotechnology company developing a novel treatment to transform chronic wound healing, today announced the publication of...

India’s first Dengue vaccine: Phase 3 trial enrollment nears completion

times of india - 04/Jul 05:36

For years now, scientists have tried to develop a safe and effective dengue vaccine. The challenge however, is that there are four different types of...

Sorry! Image not available at this time

Tonix Pharmaceuticals Announces On-line Publication of Phase 3 RESILIENT Trial Results of TNX-102 SL for Fibromyalgia in the Peer Reviewed Journal, Pain Medicine

drugs.com - 09/Jul 04:07

CHATHAM, N.J., July 09, 2025 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a clinical-stage biopharmaceutical company, today...

Sorry! Image not available at this time

How vaccine recommendations have changed in the US

wn.com - 04/Jul 09:35

The US Advisory Committee on Immunization Practices voted in June to stop recommending certain kinds of flu vaccines, a notable shift in vaccine...

Sorry! Image not available at this time

How vaccine recommendations have changed in the US

wn.com - 04/Jul 09:35

The US Advisory Committee on Immunization Practices voted in June to stop recommending certain kinds of flu vaccines, a notable shift in vaccine...

Sorry! Image not available at this time

How emergency vaccines cut infectious disease deaths

it-online.co.za - 14/Jul 09:19

Researchers at Burnet Institute, in collaboration with Gavi, the Vaccine Alliance, have provided the world’s first ever look at the historical...

This vaccine may help lower dementia risk, Oxford study finds

knowridge.com - 03/Jul 09:56

A new study from the University of Oxford has revealed a surprising benefit of the respiratory syncytial virus (RSV) vaccine: it may reduce the risk...

Sorry! Image not available at this time

ISOThrive Announces Promising Phase 2 Interim Data for Novel Heartburn Treatment and Appoints Pharma Veteran ...

wn.com - 01/Jul 23:14

ISOThrive Inc. announced promising Phase 2 interim data for ISOT-101, a novel NERD treatment for PPI partial-responders. Pharma veteran Mike Walther...

Sorry! Image not available at this time

Vaccine roll outs cut deaths and infections by 60% says study

wn.com - 11/Jul 15:04

The study looked at vaccines deployed during outbreaks of five deadly diseases....

Sorry! Image not available at this time

Moderna says mRNA flu vaccine sailed through trial, beating standard shot

wn.com - 01/Jul 23:23

An mRNA-based seasonal flu vaccine from Moderna was 27 percent more effective at preventing influenza infections than a standard flu...